- Home
- CORT vs EXLS Comparison
CORT vs EXLS Comparison
Compare CORT & EXLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- EXLS
- Stock Information
- Founded
- CORT 1998
- EXLS 1999
- Country
- CORT United States
- EXLS United States
- Employees
- CORT N/A
- EXLS N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- EXLS Business Services
- Sector
- CORT Health Care
- EXLS Consumer Discretionary
- Exchange
- CORT Nasdaq
- EXLS Nasdaq
- Market Cap
- CORT 7.6B
- EXLS 7.1B
- IPO Year
- CORT N/A
- EXLS 2006
- Fundamental
- Price
- CORT $71.32
- EXLS $42.33
- Analyst Decision
- CORT Strong Buy
- EXLS Strong Buy
- Analyst Count
- CORT 4
- EXLS 6
- Target Price
- CORT $139.00
- EXLS $51.33
- AVG Volume (30 Days)
- CORT 659.5K
- EXLS 1.2M
- Earning Date
- CORT 10-29-2025
- EXLS 10-28-2025
- Dividend Yield
- CORT N/A
- EXLS N/A
- EPS Growth
- CORT N/A
- EXLS 34.45
- EPS
- CORT 1.11
- EXLS 1.45
- Revenue
- CORT $716,080,000.00
- EXLS $1,968,978,000.00
- Revenue This Year
- CORT $30.62
- EXLS $14.72
- Revenue Next Year
- CORT $37.68
- EXLS $11.47
- P/E Ratio
- CORT $63.88
- EXLS $29.19
- Revenue Growth
- CORT 25.71
- EXLS 15.15
- 52 Week Low
- CORT $37.82
- EXLS $35.76
- 52 Week High
- CORT $117.33
- EXLS $52.43
- Technical
- Relative Strength Index (RSI)
- CORT 51.04
- EXLS 42.54
- Support Level
- CORT $67.32
- EXLS $42.55
- Resistance Level
- CORT $74.79
- EXLS $44.22
- Average True Range (ATR)
- CORT 2.43
- EXLS 0.90
- MACD
- CORT 0.10
- EXLS -0.15
- Stochastic Oscillator
- CORT 53.55
- EXLS 5.34
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
About EXLS ExlService Holdings Inc.
ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.